Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 85,000 | reported | 19 Feb 2026 | tx 34+1,175,104−336,411 |
| PENWEST PHARMACEUTICALS CO | 0 | reported | 20 Sept 2010 | tx 14+420,000−245,494 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 85,000 | 0.00 USD | deriv |
| 31 May 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 25 Mar 2025 | SALE | Trevi Therapeutics, Inc. | 2,631 | 6.60 USD | |
| 25 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 2,631 | 1.43 USD | |
| 25 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 2,631 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 116,000 | 0.00 USD | deriv |
| 19 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 16,496 | 1.43 USD | |
| 19 Aug 2024 | SALE | Trevi Therapeutics, Inc. | 16,496 | 2.96 USD | |
| 19 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 16,496 | 0.00 USD | deriv |
| 16 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 18,660 | 1.43 USD | |
| 16 Aug 2024 | SALE | Trevi Therapeutics, Inc. | 18,660 | 2.76 USD | |
| 15 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 12,745 | 1.43 USD | |
| 14 Aug 2024 | SALE | Trevi Therapeutics, Inc. | 100 | 2.75 USD | |
| 14 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 100 | 1.43 USD | |
| 15 Aug 2024 | SALE | Trevi Therapeutics, Inc. | 12,745 | 2.79 USD | |
| 14 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 100 | 0.00 USD | deriv |
| 16 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 18,660 | 0.00 USD | deriv |
| 15 Aug 2024 | EXERCISE | Trevi Therapeutics, Inc. | 12,745 | 0.00 USD | deriv |
| 29 May 2024 | SALE | Trevi Therapeutics, Inc. | 53,368 | 2.55 USD | |
| 29 May 2024 | EXERCISE | Trevi Therapeutics, Inc. | 59,354 | 2.19 USD | |
| 29 May 2024 | EXERCISE | Trevi Therapeutics, Inc. | 59,354 | 0.00 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | Trevi Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 16 Feb 2023 | GRANT_AWARD | Trevi Therapeutics, Inc. | 187,500 | 0.00 USD | deriv |
| 19 Sept 2022 | GRANT_AWARD | Trevi Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |